HMGB3 and breast carcinoma: Overexpressed HMGB3 is closely related to tumor occurrence and reduced survival in cervical cancer [12], non-small-cell lung cancer [13], breast cancer [14], bladder cancer [15], hepatocellular carcinoma [16], colorectal cancer [17], gastric cancer [18], and leukemia [19, 20].